Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus

被引:216
作者
Chakravarty, EF
Colón, I
Langen, ES
Nix, DA
El-Sayed, YY
Genovese, MC
Druzin, ML
机构
[1] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Palo Alto, CA 94304 USA
[3] Stanford Univ, Sch Med, Dept Emergency Med, Palo Alto, CA 94304 USA
关键词
systemic lupus erythematosus; flare;
D O I
10.1016/j.ajog.2005.02.063
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purpose of this study was to describe the outcomes of a 10-year cohort of pregnancies in patients with systemic lupus erythematosus and to evaluate clinical and laboratory markets for adverse outcomes. Study design: We reviewed all pregnancies in patients with systemic lupus erythematosus who were seen at Stanford University from 1991 to 2001. Univariate analyses were performed to identify potential risk factors for adverse outcomes. Results: Sixty-three pregnancies in 48 women were identified. Approximately 35% of the pregnancies occurred in women with previous renal disease and 10%, in women with previous central nervous system disease. Flares occurred in 68% of the pregnancies, the majority of which were mild to moderate. Preeclampsia complicated 12 pregnancies. Factors that were associated with premature delivery included prednisone use at conception (relative risk, 1.8), the use of antihypertensive medications (relative risk, 1.8), and a severe flare during pregnancy (relative risk, 2.0). Thrombocytopenia was associated with an increased risk of preeclampsia (relative risk, 3.2) Conclusion: Flares, most of which were mild to moderate, occured most of the pregnancies in our cohort of patients with systemic lupus erythematosus. Thrombocytopenia, hypertension, and prednisone Use may be predictive factors for particular adverse outcomes. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1897 / 1904
页数:8
相关论文
共 32 条
[1]   ACTIVATION OF THE COMPLEMENT PATHWAY - COMPARISON OF NORMAL-PREGNANCY, PREECLAMPSIA, AND SYSTEMIC LUPUS-ERYTHEMATOSUS DURING PREGNANCY [J].
ABRAMSON, SB ;
BUYON, JP .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1992, 28 (3-4) :183-187
[2]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[3]   Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies:: a prospective controlled study [J].
Brucato, A ;
Doria, A ;
Frassi, M ;
Castellino, G ;
Franceschini, F ;
Faden, D ;
Pisoni, MP ;
Solerte, L ;
Muscarà, M ;
Lojacono, A ;
Motta, M ;
Cavazzana, I ;
Ghirardello, A ;
Vescovi, F ;
Tombini, V ;
Cimaz, R ;
Gambari, P ;
Meroni, PL ;
Canesi, B ;
Tincani, A .
LUPUS, 2002, 11 (11) :716-721
[4]   Obstetrical outcome of pregnancy in patients with systemic Lupus Erythematosus.: A study of 60 cases [J].
Carmona, F ;
Font, J ;
Cervera, R ;
Muñoz, F ;
Cararach, V ;
Balasch, J .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 83 (02) :137-142
[5]  
Clark CA, 2003, J RHEUMATOL, V30, P2127
[6]   Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus:: a prospective study of 103 pregnancies [J].
Cortés-Hernández, J ;
Ordi-Ros, J ;
Paredes, F ;
Casellas, M ;
Castillo, F ;
Vilardell-Tarres, M .
RHEUMATOLOGY, 2002, 41 (06) :643-650
[7]  
El-Sayed Y Y, 2002, J Matern Fetal Neonatal Med, V12, P99, DOI 10.1080/713605623
[8]   Outcome of lupus pregnancy: a controlled study [J].
Georgiou, PE ;
Politi, EN ;
Katsimbri, P ;
Sakka, V ;
Drosos, AA .
RHEUMATOLOGY, 2000, 39 (09) :1014-1019
[9]  
GIMOVSKY ML, 1984, OBSTET GYNECOL, V63, P686
[10]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725